Search Results
Feb 24, 2026, 06:27 ET Elanco Animal Health Reports Fourth Quarter and Full Year 2025 Results
divestiture or amortization of intangible assets, that some may consider important in evaluating our performance, value or prospects for the future, (iii) they exclude items or types of items that may continue to occur from period to period in the future and (iv) they may not exclude all unusual or non-recurring
More news about: Elanco Animal Health
Feb 24, 2026, 06:00 ET Hyperscale Data Bitcoin Treasury at 605.9923 Bitcoin; Cash and Bitcoin Holdings at Approximately 142.41% of Market Capitalization
continues to be a significant disconnect between our overall asset base and the current market capitalization of the Company," stated Milton "Todd" Ault III, Executive Chairman of Hyperscale Data. "By continuing to publish our weekly update to our
More news about: Hyperscale Data Inc.
Feb 24, 2026, 04:34 ET Bitmine Immersion Technologies (BMNR) gibt bekannt, dass die ETH-Bestände 4,423 Millionen Token erreichen und die gesamten Krypto- und Bargeldbestände 9,6 Milliarden US-Dollar betragen
wird weiterhin von einer Gruppe namhafter institutioneller Investoren unterstützt, darunter Cathie Wood von ARK, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital und der Privatanleger Thomas „Tom" Lee, um das Ziel von Bitmine zu fördern, 5 % der ETH zu erwerben
More news about: Bitmine Immersion Technologies, Inc.
Feb 24, 2026, 03:33 ET Bitmine Immersion Technologies (BMNR) annonce que ses avoirs en ETH atteignent 4,423 millions de jetons, et que ses avoirs en crypto-monnaies et en liquidités atteignent 9,6 milliards de dollars
Bitmine est toujours soutenu par un groupe d'investisseurs institutionnels de premier plan, dont Cathie Wood d'ARK, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital et l'investisseur privé Thomas « Tom » Lee, pour soutenir l'objectif de Bitmine visant à acquérir 5 % du nombre
More news about: Bitmine Immersion Technologies, Inc.
Feb 24, 2026, 02:50 ET BPC Instruments receives two repeat orders from Denmark within biogas applications
AMPTS® and Gas Endeavour® III, says Dr. Jing Liu, CEO of BPC Instruments.Revenue from the orders is expected to be recognised in the first quarter of 2026.About AMPTS® IIIAMPTS® III is BPC's instrument platform for automated biochemical
More news about: BPC Instruments AB
Feb 23, 2026, 20:31 ET Collagen Market to Grow at 7.25% CAGR Through 2031 Driven by Asia-Pacific Demand and Functional Food Applications, Says Mordor Intelligence
valuation expected to rise from USD 277.72 million in 2025 to USD 297.84 million in 2026. This sector, which is categorized by types such as Type I and Type III and sourced primarily from fish skin and scales, is projected to reach USD 422.78 million by 2031, maintaining a steady 7.25% CAGR. Its applications
More news about: Mordor Intelligence Private Limited
Feb 23, 2026, 17:31 ET Acromegaly Market Poised for Significant Expansion During the Forecast Period (2026-2036) as New Treatment Options Emerge | DelveInsight
Factor 1 (IGF-1), and a safety profile similar to that of existing somatostatin analogs (SSAs), providing a solid foundation for advancing to Phase III development.AstraZeneca's ALXN2420 is an emerging small-peptide antagonist of the Growth Hormone Receptor (GHR), being developed as an
More news about: DelveInsight Business Research, LLP
Feb 23, 2026, 17:13 ET FIBRA Prologis Anuncia sus Resultados Financieros del Cuarto Trimestre y Año Completo de 2025
situación económica internacional regional y local, (ii) los cambios en los mercados financieros, tasas de interés y tipos de cambio de moneda extranjera, (iii) aumento en, o surgimiento de, competencia respecto de nuestras propiedades, (iv) los riesgos asociados con adquisiciones, enajenación y desarrollo de
More news about: FIBRA Prologis
Feb 23, 2026, 17:06 ET FIBRA Prologis Anuncia sus Resultados Financieros del Cuarto Trimestre y Año Completo de 2025
situación económica internacional regional y local, (ii) los cambios en los mercados financieros, tasas de interés y tipos de cambio de moneda extranjera, (iii) aumento en, o surgimiento de, competencia respecto de nuestras propiedades, (iv) los riesgos asociados con adquisiciones, enajenación y desarrollo de
More news about: FIBRA Prologis
Feb 23, 2026, 17:00 ET Astellas and Vir Biotechnology Announce Global Strategic Collaboration to Advance PSMA-targeting PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 for the Treatment of Prostate Cancer
(i) changes in general economic conditions and in laws and regulations, relating to pharmaceutical markets, (ii) currency exchange rate fluctuations, (iii) delays in new product launches, (iv) the inability of Astellas to market existing and new products effectively, (v) the inability of Astellas to continue
More news about: Astellas Pharma Inc.
Feb 23, 2026, 16:40 ET FIBRA Prologis Announces Fourth Quarter and Full Year 2025 Earnings Results
national, international, regional and local economic climates, (ii) changes in financial markets, interest rates and foreign currency exchange rates, (iii) increased or unanticipated competition for our properties, (iv) risks associated with acquisitions, dispositions and development of properties, (v)
More news about: FIBRA Prologis
Feb 23, 2026, 16:30 ET Keurig Dr Pepper Announces Updated Financing Plan for JDE Peet's Acquisition
but are not limited to, (i) the inherent uncertainty of estimates, forecasts and projections, (ii) global economic uncertainty or economic downturns, (iii) tariffs or the imposition of new tariffs, trade wars, barriers or restrictions, or threats of such actions and related uncertainty, (iv) the risk that
More news about: Keurig Dr Pepper
Feb 23, 2026, 16:30 ET QUAKER HOUGHTON ANNOUNCES FOURTH QUARTER AND FULL YEAR 2025 RESULTS
ResultsThe Company's fourth quarter and full year 2025 operating performance of each of its three reportable segments: (i) Americas; (ii) EMEA; and (iii) Asia/Pacific are further described below.
More news about: Quaker Chemical Corporation
Feb 23, 2026, 09:15 ET Illumina unveils roadmap of groundbreaking NovaSeq X advancements in data quality, output, speed, and flexibility
new products and services, including modifying and scaling manufacturing operations, and reliance on third-party suppliers for critical components; (iii) our ability to manufacture robust instrumentation and consumables and develop reliable software solutions; and (iv) the acceptance and adoption by customers
More news about: Illumina, Inc.
Feb 23, 2026, 09:01 ET SECuRE trial update: Another participant with undetectable PSA & negative PSMA PET
fourth cycle.The SECuRE trial will continue enrolment into the Cohort Expansion Phase with planned completion of recruitment in 2026. Phase III registrational trial planning is ongoing based on data generated to date.SYDNEY, Feb.
More news about: Clarity Pharmaceuticals
Feb 23, 2026, 08:30 ET Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 4.423 Million Tokens, and Total Crypto and Total Cash Holdings of $9.6 Billion
Bitmine remains supported by a premier group of institutional investors including ARK's Cathie Wood, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital and personal investor Thomas "Tom" Lee to support Bitmine's goal of acquiring 5% of ETHLAS
More news about: Bitmine Immersion Technologies, Inc.
Feb 23, 2026, 08:30 ET Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 4.423 Million Tokens, and Total Crypto and Total Cash Holdings of $9.6 Billion
Bitmine remains supported by a premier group of institutional investors including ARK's Cathie Wood, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital and personal investor Thomas "Tom" Lee to support Bitmine's goal of acquiring 5% of ETH
More news about: Bitmine Immersion Technologies, Inc.
Feb 23, 2026, 08:30 ET Bitmine Immersion Technologies anuncia que sus tenencias de ETH alcanzan los 4.423 millones de tokens
respaldo de un grupo de primer nivel de inversores institucionales, entre los que se incluyen Cathie Wood de ARK, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital y el inversor personal Thomas "Tom" Lee, para apoyar el objetivo de Bitmine de adquirir el 5% de ETH
More news about: Bitmine Immersion Technologies, Inc.
Feb 23, 2026, 08:30 ET Bitmine Immersion Technologies (BMNR) Công Bố Nắm Giữ Tới 4,423 Triệu Token ETH và Tổng Cộng 9,6 Tỷ USD Tiền Mã Hóa và Tiền Mặt
Bitmine hiện vẫn được hỗ trợ bởi một nhóm các nhà đầu tư tổ chức hàng đầu như Cathie Wood của ARK, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital và nhà đầu tư cá nhân Thomas "Tom" Lee nhằm giúp BitMine đạt mục tiêu sở hữu 5% ETHLAS
More news about: Bitmine Immersion Technologies, Inc.
Feb 23, 2026, 08:18 ET The Province of Entre Ríos announces the commencement of Offer to Purchase for Cash its U.S. Dollar Step Up Notes due 2028
aggregate principal amount of Tenders of the Existing Notes that have been received on or prior to the Expiration Time; (ii) the Aggregate Purchase Amount; (iii) the Tendered Aggregate Amount; (iv) the aggregate principal amount of Tenders of the Existing Notes that have been accepted; and (v) any proration of
More news about: The Province of Entre Ríos
Feb 23, 2026, 08:00 ET Legado Capital Successfully Closes $72,000,000 PDP ABS Financing for MidCon Acquisition Platform
to announce the $72 million PDP ABS issuance for Revolution Resources III, LLC ("Revolution III"). The ABS issuance facilitates Revolution III's previously announced acquisition of Amplify Energy's Oklahoma assets. Revolution III is a portfolio company of Mountain Capital Management, LLC ("Mountain Capital").
More news about: Legado Capital, LLC
Feb 23, 2026, 08:00 ET iRegene Hits Dual Global Firsts: U.S. Patient Dosed in Phase IIa for NouvNeu001 in Parkinson's and First Enrollment in China's Randomized MSA Trial for NouvNeu004
regions while promoting functional neural differentiation to potentially halt or reverse progression. China's NMPA approved the integrated Phases I–III trial application in October 2025, while the U.S. FDA has granted a special exemption and cleared an international Phase I trial, enabling efficient
More news about: iRegene Therapeutics Co., Ltd.
Feb 23, 2026, 08:00 ET CONTANGO ORE, INC. ANNOUNCES FILING AND MAILING OF SPECIAL MEETING PROXY STATEMENT IN CONNECTION WITH THE PROPOSED PLAN OF ARRANGEMENT WITH DOLLY VARDEN
patented mining claims located in the Willow Mining District about 75 miles north of Anchorage, Alaska, from the underlying owner, Alaska Hardrock Inc., (iii) mineral rights to approximately 145,000 acres of State of Alaska mining claims, and (iv) mineral rights to approximately 11,700 acres of State of Alaska
More news about: Contango Ore
Feb 23, 2026, 07:30 ET NAPCO Security Technologies to Participate in Raymond James 47th Annual Institutional Investors Conference
the Company undertakes no duty to update such information, except as required under applicable law. Contact: Francis J. Okoniewski IIIVice President of Investor Relations NAPCO Security Technologies, Inc. 800-645-9445 x 374 Mobile: 516-404-3597 fokoniewski
More news about: NAPCO Security Technologies, Inc.
Feb 23, 2026, 07:21 ET Veris Residential to Be Acquired by Affinius Capital-Led Investor Consortium for $3.4 Billion in Cash
other conditions to the completion of the proposed transaction as well as the failure to realize anticipated benefits of the proposed transaction; (iii) there may be significant transaction costs in connection with the proposed transaction and the proposed transaction may be more expensive to complete
More news about: Veris Residential, Inc.